NEW YORK (GenomeWeb) – Qiagen said this week that it has joined CANCER-ID, a public-private consortium aiming at establishing standard protocols and clinical validation for blood-based biomarkers in lung and breast cancer. Qiagen will contribute its expertise in creating liquid biopsy technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.